We are live on ! Find out more
SCM

Sarissa Capital Management Portfolio holdings

AUM $178M
1-Year Est. Return 118.43%
This Fund
S&P 500
This Quarter Est. Return
-12.11%
1 Year Est. Return
+118.43%
3 Year Est. Return
+79.96%
5 Year Est. Return
+93.71%
10 Year Est. Return
+781.26%
AUM
$454M
AUM Growth
-$60.5M
Cap. Flow
+$18.4M
Cap. Flow %
4.05%
Top 10 Hldgs %
94.65%
Holding
18
New
1
Increased
4
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$11M
2
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
+$8.6M
3
ARRY
Array Biopharma Inc
ARRY
+$6.52M
4
MDCO
Medicines Co
MDCO
+$6.04M
5
ESPR
Esperion Therapeutics
ESPR
+$2.98M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$14.6M
2
ANIP icon
ANI Pharmaceuticals
ANIP
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 97.09%
2 Miscellaneous 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$464B
$90.2M 19.89%
1,580,000
– –
ARIA
2
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$82.1M 18.09%
12,850,000
– –
BIIB icon
3
Biogen
BIIB
$32.3B
$80.7M 17.78%
310,000
– –
MDCO
4
DELISTED
Medicines Co
MDCO
$55.7M 12.27%
1,752,000
+185,000
+12% +$6.04M
DGX icon
5
Quest Diagnostics
DGX
$27.4B
$41.1M 9.05%
575,000
– –
PCRX icon
6
Pacira BioSciences
PCRX
$980M
$28.2M 6.21%
532,200
– –
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18.8M 4.13%
675,000
– –
RPTP
8
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$12.5M 2.76%
+2,725,000
New +$11M
ESPR
9
DELISTED
Esperion Therapeutics
ESPR
$10.7M 2.36%
633,000
+185,000
+41% +$2.98M
AEGR
10
DELISTED
Aegerion Pharmaceuticals
AEGR
$9.55M 2.1%
2,580,000
– –
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
$8.48M 1.87%
2,875,000
+2,175,000
+311% +$6.52M
SEEL
12
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$8.41M 1.85%
13
+7
+117% +$8.6M
VVUS
13
DELISTED
Vivus Inc
VVUS
$3.6M 0.79%
257,394
– –
AVEO
14
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.13M 0.47%
231,376
– –
RPRX
15
DELISTED
Repros Therapeutics Inc.
RPRX
$970K 0.21%
1,001,000
– –
AMGN icon
16
Amgen
AMGN
$205B
– –
-90,000
Closed -$14.6M
ANIP icon
17
ANI Pharmaceuticals
ANIP
$1.72B
– –
-31,000
Closed -$1.4M

Similar funds

FC
FACT Capital New York $178M AUM 72.35% 1-Year Est. Return
RP
RIHO Partners Tucson, Arizona $178M AUM
BC
Bulwark Capital Fernandina Beach, Florida $178M AUM 11.44% 1-Year Est. Return
MG
Montaka Global Sydney $178M AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
SCS
Southern Capital Services Daphne, Alabama $178M AUM
NCG
Newport Capital Group Red Bank, New Jersey $178M AUM 12.73% 1-Year Est. Return
RE
Rydar Equities Weatherford, Texas $178M AUM 29.33% 1-Year Est. Return

Sarissa Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sarissa Capital Management held 18 positions worth $454M, down 12% from $514M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Sarissa Capital Management deployed $18.4M of net new capital in Q1 2016, opening 1 new position and adding to 4 existing holdings. Its largest new stake was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 2,725,000 shares worth $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 100% a quarter earlier, followed by Miscellaneous.

On the sell side, the most notable exit was Amgen, an estimated $14.6M sold.

  • Sarissa Capital Management's largest Q1 2016 buy was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 2,725,000 shares worth $12.5M.
  • Sarissa Capital Management added most to Seelos Therapeutics, Inc. Common Stock in Q1 2016, an estimated $8.6M increase.
  • Sarissa Capital Management fully exited Amgen in Q1 2016, selling an estimated $14.6M.
  • Sarissa Capital Management's ten largest holdings make up 95% of its $454M portfolio in Q1 2016.
  • Sarissa Capital Management opened 1 new position and closed 2 in Q1 2016.
  • Sarissa Capital Management's portfolio value fell 12% quarter-over-quarter to $454M.

Based on Sarissa Capital Management's 13F filing for Q1 2016, filed 16 May 2016.